SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs rally is drawing attention to Morgan Stanleys bullish coverage and Musks proposed SpaceXAI-to-SpaceXSI rebrand, alongside strong breakout momentum and speculation about the companys AI potential. Bulls point to continued gains and possible short-covering, while skeptics argue the valuation is stretched and flag share unlocks as a risk.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

NVAXs sharp rally is being linked by traders to reports of a possible plague outbreak in Russia, alongside renewed attention to its vaccine business and Sanofi/Takeda partnerships; the outbreaks relevance to Novavax remains uncertain. Much of the conversation focuses on heavy short interest and a possible squeeze, while skeptics argue the move may be driven by outbreak-related speculation or momentum rather than a confirmed company catalyst.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons reported exploration of moving Nvidia AI chips into an investor-funded vehicle and leasing them back has drawn attention amid debate over its heavy AI infrastructure spending. Some traders view the move as a warning about financing risks and falling chip values, while others see balance-sheet engineering that leaves the chips in use; frustration with AMZNs choppy, underperforming share price is widespread.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Shareholder approval of Evernorths merger with Armada cleared the way for a Nasdaq debut under XRPN, with the company expected to hold a large XRP treasury; traders have piled into the low-float name amid XRP-related enthusiasm and speculation around the listing. The discussion is sharply divided between momentum bulls and traders warning that the stocks surge may outpace the value of its XRP holdings, while others debate warrant exercise and potential dilution.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

AAOIs rebound is being linked by traders to the reported completion of its at-the-market stock sale, easing dilution concerns and reviving momentum in a photonics sector buoyed by AI and data-center optics demand. The bullish breakout talk remains tempered by doubts that selling has ended and concerns about volatility and profit-taking.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR is drawing attention amid a sharp pullback, with traders focused on uncertainty over financing its AI data-center projects and the risk of further dilution, alongside doubts about management credibility and execution. Bulls cite GPU deployments and contracted growth, while some traders blame broader AI-sector risk-off rather than a company-specific setback.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors 24-month HOPE-3 open-label extension data, including a reported 76% slower upper-limb decline after patients switched to deramiocel, has renewed focus on the therapys FDA review for Duchenne muscular dystrophy. Traders are split: some see the results as supporting approval, while others emphasize statistical concerns and analyst warnings that the FDA could issue a Complete Response Letter; the share-price decline has also prompted unsubstantiated claims of short-driven pressure.

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Vaxcyte Inc

Vaxcyte shares are drawing attention after VAX-31 met the primary endpoints in its pivotal Phase 3 adult pneumococcal vaccine trial, strengthening its case against established vaccines. Traders are celebrating the clinical win but debating the sharp moves staying power, with profit-taking and proposed financing offerings raising dilution concerns.

MercadoLibre, Inc. engages in the development of an online commerce platform with a focus on e-commerce and related services. It operates through the following geographical segments: Brazil, Argentina, Mexico, and Other Countries. The Other Countries segment refers to Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Panama, Peru, Bolivia, Honduras, Nicaragua, El Salvador, Guatemala, Paraguay, Uruguay, and the United States of America. Its products provide a mechanism for buying, selling, and paying as well as collecting, generating leads, and comparing lists through e-commerce transactions. The company was founded by Marcos Eduardo Galperin on October 15, 1999 and is headquartered in Montevideo, Uruguay.

MercadoLibre Inc

MercadoLibre is rallying alongside Brazilian and Latin American stocks after traders linked the move to Flvio Bolsonaros strong first-round election showing, viewing the result as a potential boost to regional equities. The move is widely characterized as political and macro-driven rather than company-specific, though some traders question whether the election news alone justifies the jump.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians record Q3 deliveries topped expectations as the R2 ramp gained momentum, but the stock drew a sell-the-news reaction after the company reaffirmed rather than raised its full-year guidance. Bulls see volume growth as progress, while bears focus on the unchanged outlook, cash burn and the need to demonstrate a path to profitability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CNBX Pharmaceuticals, Inc. is a clinical stage company, which engages in the discovery, development, and commercialization of cannabinoid-based products and technologies for the treatment of cancer. Its products include Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome (CACS), and RCC-33, an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC). The company was founded by Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.

CNBX Pharmaceuticals Inc

Neutral Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be this week?

Current Price	$0.0001
Prev Close	$0.0001
Open	$0.0002
Dividend Yield	0.00%
50-Day Moving Average	$0.0001
Beta	9.05
Avg. Volume	4.39M
PE Ratio	-0.17

52-Week High	$0.0007
52-Week Low	$0.00
Market Capitalization	$160,577.00
EPS (Annual)	-$0.0035
Price to Book	-0.06
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

CNBXD Fundamentals